Clinical Trial Co. CEO Can't Avoid Fraud Charges Over Delay
By Ivan Moreno · November 21, 2022, 1:52 PM EST
A case against the CEO of a Miami clinical trial company indicted in a scheme to falsify research and defraud drugmakers will move forward after a federal judge rejected her claim...
To view the full article, register now.